- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
This educational activity is designed to highlight a new innovation, discovery, or update in medical science with an emphasis on how it applies to diagnosis, treatment, or outcomes in clinical care of the pediatric patient. The idea is to explain any basic science in such a way that will be educational and interesting to a general clinician; provide an update on clinical guidelines for diagnosis and treatment using evidence based medicine when applicable. This lecture can bring to the forefront new practice guidelines from the experts.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Pediatrician, Psychologist, Fellow, Resident, Nurse, Other
To discuss the effects of caregiver substance abuse on children and the approach to pediatric drug testing.
Hillary Petska, MD, Assistant Professor, Division of Child Advocacy and Protection, Medical College of Wisconsin; David Gummin, MD, Medical Director, Poison Center, Children's Hospital of Wisconsin; and Brian Peterson, MD, Milwaukee County Medical Examiner
All persons in control of content have NO relevant financial relationships to disclose.